NIH SBIR
NIH SBIR Clinical Trials: How to Classify Your Study and Choose a Funding Opportunity
Understand NIH SBIR clinical trial requirements, choose the right funding opportunity, and plan human subjects documentation before applying.
Determine whether your proposed study meets NIH’s clinical trial definition
For a startup developing a diagnostic, therapeutic, device, or digital health product, clinical trial classification shapes the entire NIH SBIR application. It affects which funding opportunity you can use, the study information you must submit, and the oversight responsibilities that follow an award. NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions to evaluate their effects on health-related biomedical or behavioral outcomes. A small feasibility study can meet this definition. So can a study involving healthy volunteers, an unapproved product, or a behavioral intervention delivered through software.
Apply NIH’s four-question decision framework to each proposed study: Does it involve human participants? Are participants prospectively assigned to an intervention? Is the study designed to evaluate the intervention’s effect on participants? Is the effect being evaluated a health-related biomedical or behavioral outcome? A yes to all four establishes an NIH clinical trial. Randomization and a control group are optional design features under this definition. For example, assigning every participant to use a therapeutic app and measuring changes in anxiety symptoms can qualify. Write down your answers, the relevant protocol details, and any questions requiring clarification before selecting a funding opportunity.
Classify diagnostic, retrospective, and usability studies carefully
Early-stage product development often sits near the boundary between clinical trials and other human subjects research. Consider a startup evaluating an algorithm against stored, previously collected images. The work may qualify as secondary research, and its human subjects status depends on details such as whether investigators can readily ascertain participants’ identities. A prospective diagnostic accuracy study also requires careful analysis: collecting samples and comparing assay results with a reference standard does not automatically establish that the study evaluates an intervention’s effect on participants. If investigators assign a diagnostic strategy that guides care and then measure health outcomes, the clinical trial definition becomes more directly relevant.
Usability studies require the same protocol-level attention. Asking clinicians to navigate a prototype interface and measuring task completion may produce a different classification from assigning patients to a medication-management tool and measuring adherence. The product category alone provides limited guidance; the assignment, study purpose, and outcomes drive the decision. Have your institutional review board or qualified human research protection office assess human subjects status and applicable exemptions. For NIH clinical trial classification questions, send the program contact a concise study synopsis containing the population, intervention, assignment method, comparator, and endpoints. NIH’s published decision tool and case studies provide useful starting points for that discussion.
Match the study to a funding opportunity that accepts clinical trials
NIH funding opportunity titles commonly identify their clinical trial designation, including “Clinical Trial Required,” “Clinical Trial Optional,” or “Clinical Trial Not Allowed.” Match your proposed studies to that designation and read the full notice of funding opportunity, or NOFO, for additional restrictions. A clinical-trial-required opportunity generally expects at least one qualifying trial, while an optional opportunity can accept applications with or without one. Participating institutes and centers may have narrower interests or policies within a broader announcement. Confirm the active opportunity, participating institute, application due date, and supported SBIR phase through Grants.gov and the NIH Guide for Grants and Contracts.
Institute fit remains essential after you establish that trials are permitted. A study may align with an institute’s disease mission while falling outside the development stage or trial scope supported by a particular opportunity. Send the scientific program contact a one-page summary explaining the clinical need, product mechanism, existing evidence, proposed study, and intended development milestone. Ask whether the institute supports that study type through the selected SBIR opportunity and whether a targeted announcement offers a stronger fit. Address the scientific rationale for conducting the study in Phase I, Phase II, or a Fast-Track application, as applicable. Trial eligibility and project readiness are separate questions that both deserve explicit answers.
Build the application around a reviewable protocol and protection plan
For applications involving human subjects, the PHS Human Subjects and Clinical Trials Information form is a central part of the submission. Prepare the appropriate study records and complete the sections required by your study classification and NOFO. These can include the study population, inclusion plans, recruitment and retention strategy, study timeline, protection of human subjects, and a protocol synopsis. Clinical trial records require additional information about design, outcomes, statistical methods, and monitoring, as applicable. NIH ASSIST supports preparation of these forms, and other authorized submission routes are available. Use the application package associated with your selected opportunity to establish the exact requirements.
Reviewers need a coherent connection between the scientific question, enrollment target, endpoints, and analysis. For a feasibility trial, explain what the sample can establish, how uncertainty will be estimated, and which results will justify further development. Support recruitment assumptions with the proposed sites’ patient populations, eligibility criteria, referral pathways, and operational capacity. Address applicable NIH inclusion policies for women, racial and ethnic minority groups, and individuals across the lifespan, with scientific or ethical justification for exclusions. Every NIH clinical trial needs a data and safety monitoring plan appropriate to its risks and complexity; the need for an independent monitoring board depends on the study and applicable requirements.
Plan regulatory readiness and trial operations before setting the budget
NIH clinical trial classification and FDA regulatory requirements involve distinct assessments. Evaluate whether a drug study requires an investigational new drug application, or IND, and whether a device study requires an investigational device exemption, or IDE, considering applicable exemptions and device risk determinations. Coordinate those assessments with qualified regulatory expertise and the reviewing IRB. Map the approvals, site agreements, product availability, and staff training needed before enrollment. Build costs from that operational plan: study coordination, participant visits, clinical procedures, data management, monitoring, and regulatory support. The effort required varies with participant risk, site count, visit frequency, follow-up duration, and the complexity of the data collected.
NIH policy expects NIH-funded clinical trials to register and report results in ClinicalTrials.gov, including trials beyond the scope of the FDA Amendments Act reporting requirements. Registration is generally due within 21 days after the first participant enrolls, and results reporting is generally due within one year after the primary completion date, subject to applicable provisions. Assign responsibility for the record, required updates, and reporting before the study begins. Also plan for applicable good clinical practice training, informed consent posting, and data management and sharing obligations. GrantUp’s PhD-level scientists and former federal reviewers can help align your study classification, opportunity selection, and application strategy. Book a free eligibility call with GrantUp to discuss your proposed NIH SBIR project.
Ready to turn this into a funded proposal?
Book a free 30-minute consultation with a senior grant consultant. We will check your eligibility, match you to the right program, and map out your submission timeline.
Learn more about our approach